379 related articles for article (PubMed ID: 34684760)
1. The Peripheral Cannabinoid Receptor Type 1 (CB
O'Sullivan SE; Yates AS; Porter RK
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684760
[TBL] [Abstract][Full Text] [Related]
2. Role of the endocannabinoid system in drug addiction.
Manzanares J; Cabañero D; Puente N; García-Gutiérrez MS; Grandes P; Maldonado R
Biochem Pharmacol; 2018 Nov; 157():108-121. PubMed ID: 30217570
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor antagonists and obesity.
Black SC
Curr Opin Investig Drugs; 2004 Apr; 5(4):389-94. PubMed ID: 15134279
[TBL] [Abstract][Full Text] [Related]
4. Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weight.
Engeli S
Handb Exp Pharmacol; 2012; (209):357-81. PubMed ID: 22249824
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
Han QW; Yuan YH; Chen NH
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
Tam J
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis.
Mallat A; Lotersztajn S
Diabetes Metab; 2008 Dec; 34(6 Pt 2):680-4. PubMed ID: 19195630
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids in the regulation of appetite and body weight.
Kirkham TC
Behav Pharmacol; 2005 Sep; 16(5-6):297-313. PubMed ID: 16148436
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of cannabinoid receptors].
Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J
Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid 1 (CB1) receptor--pharmacology, role in pain and recent developments in emerging CB1 agonists.
Talwar R; Potluri VK
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):536-44. PubMed ID: 21631407
[TBL] [Abstract][Full Text] [Related]
12. Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.
Richey JM; Woolcott O
Curr Diab Rep; 2017 Sep; 17(10):99. PubMed ID: 28913816
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
14. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.
Silvestri C; Di Marzo V
Expert Opin Investig Drugs; 2012 Sep; 21(9):1309-22. PubMed ID: 22780328
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of cannabinoid receptor ligands: current status.
Singh J; Budhiraja S
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344
[TBL] [Abstract][Full Text] [Related]
16. Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors.
Davis SN; Perkins JM
Endocr Pract; 2007; 13(7):790-804. PubMed ID: 18194939
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
18. A patent update on cannabinoid receptor 1 antagonists (2015-2018).
Amato G; Khan NS; Maitra R
Expert Opin Ther Pat; 2019 Apr; 29(4):261-269. PubMed ID: 30889997
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
[TBL] [Abstract][Full Text] [Related]
20. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
de Kloet AD; Woods SC
Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
